CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Randomized study to compare Paclitaxel/Topotecan vs. Cisplatin/Topotecan in patients with recurrent cervical cancer – AGO-Cervix–1 study
DOI 10.1055/s-0028-1088682
Bibliografische Angaben
Nachweis in CareLit
Autor:innenFC Thiel, F Hilpert, D Rein, C Liebrich, PA Fasching, MW Beckmann
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
In patients with recurrent, persistent, or metastasized cervical cancer for which a curative treatment by operation and/or radiation therapy is not possible chemotherapy is an option. But up to 75% of all these patients are assumed to have already been treated with cisplatin in conjunction with radiation therapy. It seems questionable to continue to treat the patients with cisplatin. The studies GOG 169 and 179 demo…
Zitieren
Zitierempfehlung
FC Thiel, F Hilpert, D Rein, C Liebrich, PA Fasching, MW Beckmann (2008) Randomized study to compare Paclitaxel/Topotecan vs. Cisplatin/Topotecan in patients with recurrent cervical cancer – AGO-Cervix–1 study. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-0028-1088682
Mit CareLit weiterarbeiten